185 related articles for article (PubMed ID: 33020452)
1. Local and Systemic Interleukin-32 in Esophageal, Gastric, and Colorectal Cancers: Clinical and Diagnostic Significance.
Diakowska D; Krzystek-Korpacka M
Diagnostics (Basel); 2020 Oct; 10(10):. PubMed ID: 33020452
[TBL] [Abstract][Full Text] [Related]
2. Distinct Local and Systemic Molecular Signatures in the Esophageal and Gastric Cancers: Possible Therapy Targets and Biomarkers for Gastric Cancer.
Bednarz-Misa I; Fortuna P; Diakowska D; Jamrozik N; Krzystek-Korpacka M
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630408
[TBL] [Abstract][Full Text] [Related]
3. Interleukins 4 and 13 and Their Receptors Are Differently Expressed in Gastrointestinal Tract Cancers, Depending on the Anatomical Site and Disease Advancement, and Improve Colon Cancer Cell Viability and Motility.
Bednarz-Misa I; Diakowska D; Szczuka I; Fortuna P; Kubiak A; Rosińczuk J; Krzystek-Korpacka M
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32512917
[TBL] [Abstract][Full Text] [Related]
4. Local and Systemic IL-7 Concentration in Gastrointestinal-Tract Cancers.
Bednarz-Misa I; Diakowska D; Krzystek-Korpacka M
Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31185636
[TBL] [Abstract][Full Text] [Related]
5. Low expression of LncRNA-CAF attributed to the high expression of HIF1A in esophageal squamous cell carcinoma and gastric cancer patients.
Bahramian S; Sahebi R; Roohinejad Z; Delshad E; Javid N; Amini A; Razavi AE; Shafiee M; Shamsabadi FT
Mol Biol Rep; 2022 Feb; 49(2):895-905. PubMed ID: 35040008
[TBL] [Abstract][Full Text] [Related]
6. Keratin 17 activates AKT signalling and induces epithelial-mesenchymal transition in oesophageal squamous cell carcinoma.
Liu Z; Yu S; Ye S; Shen Z; Gao L; Han Z; Zhang P; Luo F; Chen S; Kang M
J Proteomics; 2020 Jan; 211():103557. PubMed ID: 31669361
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-33-nuclear factor-κB-CCL2 signaling pathway promotes progression of esophageal squamous cell carcinoma by directing regulatory T cells.
Yue Y; Lian J; Wang T; Luo C; Yuan Y; Qin G; Zhang B; Zhang Y
Cancer Sci; 2020 Mar; 111(3):795-806. PubMed ID: 31883400
[TBL] [Abstract][Full Text] [Related]
8. LTBP1 promotes esophageal squamous cell carcinoma progression through epithelial-mesenchymal transition and cancer-associated fibroblasts transformation.
Cai R; Wang P; Zhao X; Lu X; Deng R; Wang X; Su Z; Hong C; Lin J
J Transl Med; 2020 Mar; 18(1):139. PubMed ID: 32216815
[TBL] [Abstract][Full Text] [Related]
9. Elevation of circulating interleukin-8 is related to lymph node and distant metastases in esophageal squamous cell carcinomas--implication for clinical evaluation of cancer patient.
Krzystek-Korpacka M; Matusiewicz M; Diakowska D; Grabowski K; Blachut K; Konieczny D; Kustrzeba-Wojcicka I; Terlecki G; Banas T
Cytokine; 2008 Mar; 41(3):232-9. PubMed ID: 18182303
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
[TBL] [Abstract][Full Text] [Related]
11. Subsite heterogeneity in the profiles of circulating cytokines in colorectal cancer.
Krzystek-Korpacka M; Zawadzki M; Kapturkiewicz B; Lewandowska P; Bednarz-Misa I; Gorska S; Witkiewicz W; Gamian A
Cytokine; 2018 Oct; 110():435-441. PubMed ID: 29801973
[TBL] [Abstract][Full Text] [Related]
12. Promoter hypomethylation mediated upregulation of MicroRNA-10b-3p targets FOXO3 to promote the progression of esophageal squamous cell carcinoma (ESCC).
Lu YF; Yu JR; Yang Z; Zhu GX; Gao P; Wang H; Chen SY; Zhang J; Liu MY; Niu Y; Wei XM; Wang W; Ye FJ; Zhang LX; Zhao Y; Sun GG
J Exp Clin Cancer Res; 2018 Dec; 37(1):301. PubMed ID: 30514328
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of the long noncoding RNA PCAT-1 correlates with advanced clinical stage and poor prognosis in esophageal squamous carcinoma.
Shi WH; Wu QQ; Li SQ; Yang TX; Liu ZH; Tong YS; Tuo L; Wang S; Cao XF
Tumour Biol; 2015 Apr; 36(4):2501-7. PubMed ID: 25731728
[TBL] [Abstract][Full Text] [Related]
14. SPI1-Mediated Upregulation of the
Luo FF; Wang J; Zhang ZF; Lin ST; Huang TJ; Liu BQ; Fan ML; Peng LX; Zheng ST; Yang CF; Huang BJ
Front Biosci (Landmark Ed); 2023 Sep; 28(9):212. PubMed ID: 37796690
[TBL] [Abstract][Full Text] [Related]
15. GEFT protein expression in digestive tract malignant tumors and its clinical significance.
Wang Y; Zhang B; Gao G; Zhang Y; Xia Q
Oncol Lett; 2019 Nov; 18(5):5577-5590. PubMed ID: 31620201
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of PAX2 promotes the metastasis of esophageal cancer through interleukin-5.
Liu P; Gao Y; Huan J; Ge X; Tang Y; Shen W; Tian Y; Shen W; Zou S; Zhou J; Zhang S
Cell Physiol Biochem; 2015; 35(2):740-54. PubMed ID: 25613757
[TBL] [Abstract][Full Text] [Related]
17. Macrophage inhibitory factor 1 acts as a potential biomarker in patients with esophageal squamous cell carcinoma and is a target for antibody-based therapy.
Wang XB; Jiang XR; Yu XY; Wang L; He S; Feng FY; Guo LP; Jiang W; Lu SH
Cancer Sci; 2014 Feb; 105(2):176-85. PubMed ID: 24383865
[TBL] [Abstract][Full Text] [Related]
18. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
[TBL] [Abstract][Full Text] [Related]
19. HER2 gene amplification in esophageal squamous cell carcinoma is less than in gastroesophageal junction and gastric adenocarcinoma.
Huang JX; Zhao K; Lin M; Wang Q; Xiao W; Lin MS; Yu H; Chen P; Qian RY
Oncol Lett; 2013 Jul; 6(1):13-18. PubMed ID: 23946770
[TBL] [Abstract][Full Text] [Related]
20. Impact of intra-tumoral IL17A and IL32 gene expression on T-cell responses and lymph node status in breast cancer patients.
Bhat S; Gardi N; Hake S; Kotian N; Sawant S; Kannan S; Parmar V; Desai S; Dutt A; Joshi NN
J Cancer Res Clin Oncol; 2017 Sep; 143(9):1745-1756. PubMed ID: 28470472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
